Assyro AI

Purple Book product · Reference 351(a)

Gammaked, Gamunex-C

Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified

351(a)BLA 125046RxLicensed Grifols Therapeutics LLC

Oct 20, 2025

Approved

Reference 351(a)

License type

Rx

Marketing

None

Listed patents

Gammaked, Gamunex-C (Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified) is Grifols Therapeutics LLC's FDA-licensed reference biologic, approved under a 351(a) BLA in 2025. No biosimilars referencing Gammaked, Gamunex-C are listed in the Purple Book yet.

Sourced from the FDA Purple Book · verified Jul 02, 2026

Key dates

  1. Orphan exclusivity ends

    7-year orphan-drug exclusivity window.

    Sep 12, 2015

    11 yr ago

  2. Approval

    Approval date of this BLA submission.

    Oct 20, 2025

    9 mo ago

  3. Today

Pharmaceutical detail

Strength

10G/100ML

Dosage form

Injection

Route

Subcutaneous

Presentation

Bag

Center

CBER

License number

1871

Product number

018

Submission type

Supplement

Supplement number

2129

Change type

Not listed

Reference product family

View full family

This is the reference (originator) product. No biosimilars or interchangeables reference it in the Purple Book yet.

18 additional BLA records for this product (other strengths or presentations) are in the same reference family.

Patent list

No patent-list records were published for this product. The Purple Book patent list reflects the statutory patent exchange under the BPCIA and is not exhaustive.

Source provenance

Source kind · Advanced Search
Checked Jul 02, 2026
  • advanced-searchAdvanced Search · Jul 02, 2026
  • monthly-downloadMonthly download · Jul 02, 2026

Change history

  • v5Jul 02, 2026
  • v4Jul 02, 2026
  • v3Jul 02, 2026
  • v2Jul 02, 2026
  • v1Jul 02, 2026

Frequently asked questions

Does Gammaked, Gamunex-C have approved biosimilars?

No 351(k) biosimilars or interchangeable biosimilars referencing Gammaked, Gamunex-C are listed in the FDA Purple Book yet.

What is Gammaked, Gamunex-C's BLA number?

Gammaked, Gamunex-C is licensed under BLA 125046, held by Grifols Therapeutics LLC.

When was Gammaked, Gamunex-C approved by the FDA?

Gammaked, Gamunex-C was approved by the FDA on Oct 20, 2025.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.